Journal profile

EMBO reports

Publisher: Nature Publishing Group
ISSN1469-221X | 1469-3178 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
4.46
Citation rate 6.96 4,232 total citations
h5-index 73 h5 depth signal
Cited share 86.7% 569 of 656
Total citations 4,232 Citation footprint
Metric signal 6.39 External metric anchor
Self-citation 0.5% 22 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 818
Germany 573
China 512
United Kingdom 417
France 252

Citing Fields of Research

Cell Biology 924
Genetics & Genomics 473
Immunology 380
Cancer, Autophagy & Apoptosis 327
Scientometrics & Research Ethics 286

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 7,037 Articles tracked across the journal lifetime
Indexed publication set 656 569 cited publications
Last 12 months 354 29.5 publications/month
Open access share 99.7% 353 OA publications in the last year
Leading citing country United States 818 citing publications
Leading citing field Cell Biology 924 citing publications
Latest tracked publication 19 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v1n1, July 2000-
PubMed
v1n1, July 2000-
PMC
Active Coverage
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Cell Biology Immunology Genetics & Genomics Cell Differentiation & Development DNA Damage Cancer, Autophagy & Apoptosis

Issuing & Sponsoring Bodies

Contributor
European Molecular Biology Organization

Broad Categories

Molecular Biology Cancer, Autophagy & Apoptosis Cell Biology Genetics & Genomics Cancer & Development DNA Damage Immunology Nucleic Acids Chemistry

MeSH Descriptors

Molecular Biology

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

03
Chun-Yen Yang, Bayan Chami, Chiara Ursino et al.
TREX1 has recently emerged as a promising therapeutic target in cancer owing to its role in degrading cytosolic DNA and suppressing type I interferon signaling. However, the nature of the immunostimulatory DNA species degraded by TREX1 r...

Bibliographical & Catalog Notes

Title from cover.

Print issues ceased with v. 16, no. 12 (Dec. 2015).

Also issued online.

v. 1, no. 1 (July 2000)20010321 Notice not published Printed on acid-free paper